Dominican Republic vs Iraq: Prevalence rate of hypertension in men aged 30-79
Dominican Republic
49
in 2019
Iraq
48.4
in 2019
Dominican Republic rank
18th
Iraq rank
21st
Prevalence rate of hypertension in men aged 30-79 over time
- Dominican Republic
- Iraq
How they compare
Dominican Republic currently reports 49 against 48.4 in Iraq, a difference of 0.6.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Iraq ahead.
Dominican Republic ranks 18th and Iraq ranks 21st of 195 countries.
Across the 3 decades both report, Dominican Republic averaged higher in 2 and Iraq in 1.
Head to head by decade
| Decade | Dominican Republic | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 42.53 | 43.24 | 0.71 | Iraq |
| 2000s | 46.53 | 45.48 | 1.05 | Dominican Republic |
| 2010s | 48.76 | 47.5 | 1.26 | Dominican Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, Dominican Republic or Iraq?
- Dominican Republic, at 49 against 48.4 in Iraq as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between Dominican Republic and Iraq?
- 0.6, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Iraq?
- 30 years are reported by both, from 1990 to 2019.
- How do Dominican Republic and Iraq rank globally for prevalence rate of hypertension in men aged 30-79?
- Dominican Republic ranks 18th and Iraq ranks 21st of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.